I first wrote a blog post of this story yesterday.
by David Prentice
December 14, 2009
The latest success story comes from Australia. Ben Leahy, 20, was in a wheelchair and experiencing vision problems when he was treated earlier in 2009. Ben is now walking after treatment with adult stem cells. The treatment involves isolating the patient’s bone marrow adult stem cells, giving the patient mild chemotherapy to destroy the rogue immune cells that are attacking the nervous system, then re-injecting the patient’s adult stem cells.
While the Australian group has not yet published their results, the technique mirrors the treatment results published in 2009 in Lancet Neurology by Dr. Richard Burt’s team at Northwestern, where they reported that they had reversed the neurological dysfunction of early-stage multiple sclerosis patients.
As Dr. Burt noted:
“This is the first time we have turned the tide on this disease.”
CLICK HERE to continue reading and to watch MS Patient videos of this treatment
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Keep up-to-date with MS related News (as seen above), when registered with us. Visit our website to register NOW. It will not take more than 30 seconds to register and once accomplished, you will then receive our weekly MS related e-Newsletter, which is currently being received in 58 countries by more than 6000 e-recipients. Click HERE to register. – Thank You
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Stay informed with MS news and information - Sign-up here
For MS patients, caregivers or clinicians, Care to chat about MS? Join Our online COMMUNITY
Categories
Latest Blog Posts
- VIRTUAL Physical Therapy – (each month) – “MOVING WITH MS” –
- The New MS Diagnostic Criteria: What You Need To Know
- Octave wins grant to develop blood test for measuring MS progression
- With new data, Quantum moves closer to launching trial of Lucid-MS – a potential treatment for targeting demyelination
- When living with MS, we have to be open to change in our routine
- ECTRIMS 2025: Immunic chief medical officer discusses vidofludimus calcium for MS
- ECTRIMS 2025: Medical director at Genentech discusses potential of Ocrevus as a pediatric MS treatment
- Maternal and neonatal outcomes associated with natalizumab exposure during pregnancy in patients with multiple sclerosis
- A sense of humor is a powerful act of resistance when living with MS
- Inflammatory Brain Cells Driving Progressive MS Discovered – Neuroscience News
- video – Multiple Sclerosis Starts Years Before Symptom Onset
- 2024 Revisions to McDonald Diagnostic Criteria for Multiple Sclerosis Published
- REPAIRING MS – The Quest to Rebuild Myelin
- Fasting and MS , by Brandon Beaber, MD
- Exercise and Cognition in Multiple Sclerosis in 2025: Forward Momentum or Going Nowhere Fast?
- What Does It Mean to Die From ‘Complications of MS’?
- Role of vitamin D as adjuvant therapy on multiple sclerosis:
- MS vision problems: Common eye symptoms
- Broca’s Aphasia
- Researchers Find Gut Bacteria That May Be Linked to MS